期刊档案 · Medicine-Medicine (all)
Chinese Medical Sciences Journal
ISSN 1001-9294 · eISSN 2352-4014 · Elsevier
Chinese Medical Sciences Journal 完全开放获取,收取 APC,金额未公布,2025 年发文 39 篇,Scopus 收录。
研究范围
研究范围与定位
Chinese Medical Sciences Journal 由 Elsevier 出版。按 OpenAlex 近年发文统计,该刊主要发表 Vasculitis and related conditions、Anesthesia and Sedative Agents、Medical Imaging Techniques and Applications 等主题的论文,这 3 个主题约占 16%,主导子领域为 Radiology, Nuclear Medicine and Imaging。(根据 OpenAlex 主题统计与中科院分区数据生成)
The journal is dedicated to publishing reliable research, strictly adhering to international publishing ethics and maintaining a stringent peer review process. Its mission is to disseminate the latest scientific findings and disciplinary advancements in the medical sciences, thereby fostering academic exchange and collaboration worldwide.The journal encompasses a broad spectrum of fields, including fundamental medicine, clinical medicine, preventive medicine and public health, biomedical engineering, and traditional Chinese medicine, with special interests in emerging interdisciplinary research and cutting-edge developments at the intersections of medical science.
摘自期刊官网 Aims & Scope
研究方向(LetPub):Medicine-Medicine (all)
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Vasculitis and related conditionsMedicine5.8%
- Anesthesia and Sedative AgentsMedicine5.1%
- Medical Imaging Techniques and ApplicationsMedicine5.1%
- Artificial Intelligence in Healthcare and EducationMedicine5.1%
- Anesthesia and Pain ManagementMedicine4.8%
- Advanced MRI Techniques and ApplicationsMedicine4.8%
- MRI in cancer diagnosisMedicine4.8%
- Radiomics and Machine Learning in Medical ImagingMedicine4.8%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》( 2026年3月发布)未收录
该期刊未被此版本分区表收录。
期刊分区表( 2023年12月旧的升级版)未收录
该期刊未被此版本分区表收录。
CiteScore 分区(Scopus,2026 年 6 月版)
| 学科 | 分区 | 排名 | 百分位 |
|---|---|---|---|
| General Medicine | Q2 | 265/669 | — |
Scopus 按 CiteScore 在每个学科内为期刊排名,百分位 75 及以上为 Q1,每 25 为一档;与中科院分区是不同体系。LetPub
数据库收录
ScopusLetPub
国际期刊预警名单:各版本均未列入LetPub
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- CiteScore 2026-06
- 1.9LetPub ·
- CiteScore(出版商公布)
- 1.9出版商官网 ·
- SJR 2026-06
- 0.29LetPub ·
- SNIP 2026-06
- 0.4LetPub ·
- h-index
- 25OpenAlex ·
- i10-index
- 175OpenAlex ·
- 两年平均被引
- 1.41OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
逐年发文量 OpenAlex 统计 · 累计 896 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 19 | 19 | 349 |
| 2025 | 39 | 39 | 506 |
| 2024 | 34 | 34 | 511 |
| 2023 | 35 | 35 | 508 |
| 2022 | 50 | 50 | 513 |
| 2021 | 61 | 61 | 588 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 评审方式
- 双盲同行评审出版商官网
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
所有文章开放获取,通常向作者收取文章处理费(APC)。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| 出版商官网 | 有,金额未公布 | — | — |
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点3 项,摘自作者指南
- 关键词
- ≥ 3 个
- 参考文献格式
- 顺序编码制(按引用顺序编号)
- Highlights(研究亮点)
- 可选
接收的文章类型10 种,含篇幅限制
- editorialcommentary and analysis to the current issue of the journal, aiming to influence public opinion, and promote critical thinking, and sometimes motivate people to…未说明篇幅
- narrative reviewChinese Medical Sciences Journal publishes:Article typeRequirementsResearch articleComplete academic investigation that covers a significant advance in a specia…正文 ≤ 5,000 词
- opinionChinese Medical Sciences Journal publishes:Article typeRequirementsResearch articleComplete academic investigation that covers a significant advance in a specia…未说明篇幅
- perspectiveChinese Medical Sciences Journal publishes:Article typeRequirementsResearch articleComplete academic investigation that covers a significant advance in a specia…未说明篇幅
- research articleComplete academic investigation that covers a significant advance in a specialty. It includes a structured abstract under 300 words, full text under 3500 words,…未说明篇幅
- reviewChinese Medical Sciences Journal publishes:Article typeRequirementsResearch articleComplete academic investigation that covers a significant advance in a specia…未说明篇幅
- short communicationPresent innovative preliminary research or important observations through concise reports for prompt communication. It need a structured abstracts and keywords,…未说明篇幅
- systematic reviewChinese Medical Sciences Journal publishes:Article typeRequirementsResearch articleComplete academic investigation that covers a significant advance in a specia…未说明篇幅
- think tank forumPresent authoritative, policy-oriented, and advisory perspectives on critical topics related to healthcare policies. The manuscript should be 2,500-4,000 words …未说明篇幅
- viewpointChinese Medical Sciences Journal publishes:Article typeRequirementsResearch articleComplete academic investigation that covers a significant advance in a specia…未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、许可与版权、开放获取、同行评审、查重、预印本
- AI 使用 Declaration of generative AI use
作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
原文 ↗出版商官网 ·- 作者资格 Group authorship
团体署名指将文章归属于一个明确且具名的作者群体,须在投稿时于标题页声明。 模型中文摘要
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
原文 ↗出版商官网 ·- 利益冲突 Declaration of competing interests
所有作者必须披露可能不当影响或偏袒其工作的与他人或组织的财务及个人关系。 模型中文摘要
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
原文 ↗出版商官网 ·- 许可与版权 Creative Commons Attribution-NonCommercial (CC BY-NC)
该许可允许非商业目的分发、复制、改编及文本数据挖掘文章,但须注明出处、附许可链接并说明是否修改。 模型中文摘要
Allows users to: distribute and copy the article; create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); and text or data mine the article. These uses are permitted only for non-commercial purposes, and provided the user: gives appropriate credit to the author(s) (wi…
原文 ↗出版商官网 ·- 开放获取 KeAi Guide for authors: Open Access
本刊为开放获取期刊,所有文章立即且永久免费供所有人阅读和下载,作者或其资助方/机构需支付文章出版费(APC)。 模型中文摘要
This is an open access journal: all articles will be immediately and permanently free for everyone to read and download. To provide open access, this journal has an open access fee (also known as an article publishing charge APC) which needs to be paid by the authors or on their behalf e.g. by their research funder or institution. Permitted third party (re)use is defined by the following Creative …
原文 ↗出版商官网 ·- 同行评审 Peer review
本刊实行双盲同行评审,投稿先由编辑评估,合格稿件通常送至少两名审稿人独立评审,录用与否由编辑决定且为最终决定。 模型中文摘要
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors to determine suitability for publication in this journal. If your submission is deemed suitable, it will typically be sent to a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected will…
原文 ↗出版商官网 ·- 查重
KeAi期刊的投稿会在编辑系统内自动使用iThenticate的CrossCheck进行查重筛查,以检测抄袭问题。 模型中文摘要
Submissions to KeAi journals are automatically screened using iThenticate's CrossCheck within the editorial system to detect plagiarism issues including instances of overlapping and similar text in submitted manuscripts.
原文 ↗出版商官网 ·- 预印本 Preprint sharing
作者可按Elsevier文章共享政策分享预印本,在预印本服务器上分享不视为已发表。 模型中文摘要
Authors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Elsevier
- ISSN
- 1001-9294
- 电子版 ISSN
- 2352-4014
常见问题
关于 Chinese Medical Sciences Journal 的常见问题
Chinese Medical Sciences Journal 的投稿格式要求是什么?
据期刊作者指南:关键词:≥ 3 个;参考文献格式:顺序编码制(按引用顺序编号);Highlights:可选。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
Chinese Medical Sciences Journal 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,Chinese Medical Sciences Journal 被 Scopus 收录。
Chinese Medical Sciences Journal 是开放获取期刊吗?版面费多少?
Chinese Medical Sciences Journal 为完全开放获取。收取 APC,金额未公布。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。